{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:a38a83ce-c9fb-4712-9911-bcef682a508f","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T01:11:49.244707+00:00","published_at":"2026-10-16T13:53:35.550143+00:00","section":"evidence","data":{"state":"PUBLISHED","evidence":[{"evidence_id":"alpha:projection-evidence:31146fafece2a05cc6fce81fd6a5598dce534403a1ca7bbd2ae10416e539bcb9","aliases":[],"source_type":"canonical_identity","source_family":"open_web","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/aeon-biopharma-inc","title":"Alpha canonical company public projection","identifier":null,"locator":null,"source_date":null,"retrieved_at":"2026-10-16T13:53:35.550143+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"open_web","score":35,"source_family":"open_web","reasons":["Matched open_web source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:a38a83ce-c9fb-4712-9911-bcef682a508f:legal_name:1","stance":"supports"},{"claim_id":"alpha:claim:company:a38a83ce-c9fb-4712-9911-bcef682a508f:entity_status:3","stance":"supports"},{"claim_id":"alpha:claim:company:a38a83ce-c9fb-4712-9911-bcef682a508f:published_fact:4","stance":"supports"},{"claim_id":"alpha:claim:company:a38a83ce-c9fb-4712-9911-bcef682a508f:security_listing:8","stance":"supports"},{"claim_id":"alpha:claim:company:a38a83ce-c9fb-4712-9911-bcef682a508f:security_listing:9","stance":"supports"}],"claim_ids":["alpha:claim:company:a38a83ce-c9fb-4712-9911-bcef682a508f:legal_name:1","alpha:claim:company:a38a83ce-c9fb-4712-9911-bcef682a508f:entity_status:3","alpha:claim:company:a38a83ce-c9fb-4712-9911-bcef682a508f:published_fact:4","alpha:claim:company:a38a83ce-c9fb-4712-9911-bcef682a508f:security_listing:8","alpha:claim:company:a38a83ce-c9fb-4712-9911-bcef682a508f:security_listing:9"]},{"evidence_id":"alpha:projection-evidence:document:9bbe390fcd779e197990c10b5bb8397b783e40683f46c35661370b097824c5ca","aliases":[],"source_type":"sec_proxy","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1837607/000183760725000104/aeon-20251229xdef14a.htm","title":"AEON Biopharma, Inc. DEF 14A 2025-12-29","identifier":null,"locator":null,"source_date":"2025-12-29","retrieved_at":"2026-04-24T20:05:01.328+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:a38a83ce-c9fb-4712-9911-bcef682a508f:leadership_role:5","stance":"supports"}],"claim_ids":["alpha:claim:company:a38a83ce-c9fb-4712-9911-bcef682a508f:leadership_role:5"]},{"evidence_id":"alpha:projection-evidence:document:2fde19d72698c6a666473ef802ce2f2e85217d54db4c1f87960d1a0c72b7d806","aliases":[],"source_type":"sec_filing","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1837607/000183760726000033/aeon-20260429xdef14a.htm","title":"AEON DEF 14A executive officers","identifier":null,"locator":null,"source_date":"2026-04-29T00:00:00+00:00","retrieved_at":"2026-05-15T22:13:53.72044+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:a38a83ce-c9fb-4712-9911-bcef682a508f:leadership_role:6","stance":"supports"}],"claim_ids":["alpha:claim:company:a38a83ce-c9fb-4712-9911-bcef682a508f:leadership_role:6"]},{"evidence_id":"alpha:projection-evidence:document:4803cad0315f1bee7e433e3adfa493a993d78da3ef6d37caa94c692c09f155d5","aliases":[],"source_type":"sec_filing","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1837607/000183760726000033/aeon-20260429xdef14a.htm","title":"AEON DEF 14A executive officers","identifier":null,"locator":null,"source_date":"2026-04-29T00:00:00+00:00","retrieved_at":"2026-05-15T22:13:53.217543+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:a38a83ce-c9fb-4712-9911-bcef682a508f:leadership_role:7","stance":"supports"}],"claim_ids":["alpha:claim:company:a38a83ce-c9fb-4712-9911-bcef682a508f:leadership_role:7"]}]},"claims":[{"id":"alpha:claim:company:a38a83ce-c9fb-4712-9911-bcef682a508f:legal_name:1","subject_id":"alpha:company:a38a83ce-c9fb-4712-9911-bcef682a508f","predicate":"schema:legalName","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"AEON Biopharma, Inc.","claim_type":"legal_name","predicate_id":"alpha:predicate:legal_name","predicate_version":1,"machine_key":"legal_name","human_label":"Legal Name","governed_predicate":true,"machine_value":"AEON Biopharma, Inc.","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:53:35.550143+00:00","sources":[{"id":"alpha:projection-evidence:31146fafece2a05cc6fce81fd6a5598dce534403a1ca7bbd2ae10416e539bcb9","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/aeon-biopharma-inc","source_date":null,"retrieved_at":"2026-10-16T13:53:35.550143+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:53:35.550143+00:00","reviewed_at":"2026-10-16T13:53:35.550143+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a38a83ce-c9fb-4712-9911-bcef682a508f:entity_status:3","subject_id":"alpha:company:a38a83ce-c9fb-4712-9911-bcef682a508f","predicate":"alpha:entityStatus","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Public listing published","claim_type":"entity_status","predicate_id":"alpha:predicate:entity_status","predicate_version":1,"machine_key":"entity_status","human_label":"Entity Status","governed_predicate":true,"machine_value":"Public listing published","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:53:35.550143+00:00","sources":[{"id":"alpha:projection-evidence:31146fafece2a05cc6fce81fd6a5598dce534403a1ca7bbd2ae10416e539bcb9","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/aeon-biopharma-inc","source_date":null,"retrieved_at":"2026-10-16T13:53:35.550143+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:53:35.550143+00:00","reviewed_at":"2026-10-16T13:53:35.550143+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a38a83ce-c9fb-4712-9911-bcef682a508f:published_fact:4","subject_id":"alpha:company:a38a83ce-c9fb-4712-9911-bcef682a508f","predicate":"alpha:country","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"US","claim_type":"published_fact","predicate_id":"alpha:predicate:published_fact","predicate_version":1,"machine_key":"published_fact","human_label":"Published Fact","governed_predicate":true,"machine_value":"US","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:53:35.550143+00:00","sources":[{"id":"alpha:projection-evidence:31146fafece2a05cc6fce81fd6a5598dce534403a1ca7bbd2ae10416e539bcb9","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/aeon-biopharma-inc","source_date":null,"retrieved_at":"2026-10-16T13:53:35.550143+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:53:35.550143+00:00","reviewed_at":"2026-10-16T13:53:35.550143+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a38a83ce-c9fb-4712-9911-bcef682a508f:leadership_role:5","subject_id":"alpha:company:a38a83ce-c9fb-4712-9911-bcef682a508f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:seongsoo-park","object_label":"Shinyoung Park","object_source_name_forms":[],"value":"Shinyoung Park: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:seongsoo-park","name":"Shinyoung Park"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:53:35.550143+00:00","sources":[{"id":"alpha:projection-evidence:document:9bbe390fcd779e197990c10b5bb8397b783e40683f46c35661370b097824c5ca","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"AEON Biopharma, Inc. DEF 14A 2025-12-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1837607/000183760725000104/aeon-20251229xdef14a.htm","source_date":"2025-12-29","retrieved_at":"2026-04-24T20:05:01.328+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-12-29","effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:53:35.550143+00:00","reviewed_at":"2026-10-16T13:53:35.550143+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a38a83ce-c9fb-4712-9911-bcef682a508f:leadership_role:6","subject_id":"alpha:company:a38a83ce-c9fb-4712-9911-bcef682a508f","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:alex-wilson","object_label":"Alex Wilson","object_source_name_forms":[],"value":"Alex Wilson: Chief Legal Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:alex-wilson","name":"Alex Wilson"},"title":"Chief Legal Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-29","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-29","valid_to":null,"recorded_at":"2026-10-16T13:53:35.550143+00:00","sources":[{"id":"alpha:projection-evidence:document:2fde19d72698c6a666473ef802ce2f2e85217d54db4c1f87960d1a0c72b7d806","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AEON DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1837607/000183760726000033/aeon-20260429xdef14a.htm","source_date":"2026-04-29T00:00:00+00:00","retrieved_at":"2026-05-15T22:13:53.72044+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-29T00:00:00+00:00","effective_from":"2026-04-29","effective_until":null,"observed_at":"2026-10-16T13:53:35.550143+00:00","reviewed_at":"2026-10-16T13:53:35.550143+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a38a83ce-c9fb-4712-9911-bcef682a508f:leadership_role:7","subject_id":"alpha:company:a38a83ce-c9fb-4712-9911-bcef682a508f","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:robert-bancroft","object_label":"Robert Bancroft","object_source_name_forms":[],"value":"Robert Bancroft: President, Chief Executive Officer and Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:robert-bancroft","name":"Robert Bancroft"},"title":"President, Chief Executive Officer and Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-29","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-29","valid_to":null,"recorded_at":"2026-10-16T13:53:35.550143+00:00","sources":[{"id":"alpha:projection-evidence:document:4803cad0315f1bee7e433e3adfa493a993d78da3ef6d37caa94c692c09f155d5","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AEON DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1837607/000183760726000033/aeon-20260429xdef14a.htm","source_date":"2026-04-29T00:00:00+00:00","retrieved_at":"2026-05-15T22:13:53.217543+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-29T00:00:00+00:00","effective_from":"2026-04-29","effective_until":null,"observed_at":"2026-10-16T13:53:35.550143+00:00","reviewed_at":"2026-10-16T13:53:35.550143+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a38a83ce-c9fb-4712-9911-bcef682a508f:security_listing:8","subject_id":"alpha:company:a38a83ce-c9fb-4712-9911-bcef682a508f","predicate":"alpha:hasSecurityListing","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"AEON (NYSE)","claim_type":"security_listing","predicate_id":"alpha:predicate:security_listing","predicate_version":1,"machine_key":"security_listing","human_label":"Security Listing","governed_predicate":true,"machine_value":{"kind":"security_listing","ticker":"AEON","exchange":"NYSE","exchange_display":"NYSE","mic":"XNYS","currency":"Unavailable","security_type":"equity","listing_status":"active","is_primary":true},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:53:35.550143+00:00","sources":[{"id":"alpha:projection-evidence:31146fafece2a05cc6fce81fd6a5598dce534403a1ca7bbd2ae10416e539bcb9","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/aeon-biopharma-inc","source_date":null,"retrieved_at":"2026-10-16T13:53:35.550143+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:53:35.550143+00:00","reviewed_at":"2026-10-16T13:53:35.550143+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a38a83ce-c9fb-4712-9911-bcef682a508f:security_listing:9","subject_id":"alpha:company:a38a83ce-c9fb-4712-9911-bcef682a508f","predicate":"alpha:hasSecurityListing","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"AEON (NYSE AMERICAN)","claim_type":"security_listing","predicate_id":"alpha:predicate:security_listing","predicate_version":1,"machine_key":"security_listing","human_label":"Security Listing","governed_predicate":true,"machine_value":{"kind":"security_listing","ticker":"AEON","exchange":"NYSE AMERICAN","exchange_display":"NYSE AMERICAN","mic":"XNYS","currency":"Unavailable","security_type":"equity","listing_status":"active","is_primary":true},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:53:35.550143+00:00","sources":[{"id":"alpha:projection-evidence:31146fafece2a05cc6fce81fd6a5598dce534403a1ca7bbd2ae10416e539bcb9","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/aeon-biopharma-inc","source_date":null,"retrieved_at":"2026-10-16T13:53:35.550143+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:53:35.550143+00:00","reviewed_at":"2026-10-16T13:53:35.550143+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:31146fafece2a05cc6fce81fd6a5598dce534403a1ca7bbd2ae10416e539bcb9","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/aeon-biopharma-inc","source_date":null,"retrieved_at":"2026-10-16T13:53:35.550143+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:9bbe390fcd779e197990c10b5bb8397b783e40683f46c35661370b097824c5ca","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"AEON Biopharma, Inc. DEF 14A 2025-12-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1837607/000183760725000104/aeon-20251229xdef14a.htm","source_date":"2025-12-29","retrieved_at":"2026-04-24T20:05:01.328+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:2fde19d72698c6a666473ef802ce2f2e85217d54db4c1f87960d1a0c72b7d806","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AEON DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1837607/000183760726000033/aeon-20260429xdef14a.htm","source_date":"2026-04-29T00:00:00+00:00","retrieved_at":"2026-05-15T22:13:53.72044+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:4803cad0315f1bee7e433e3adfa493a993d78da3ef6d37caa94c692c09f155d5","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AEON DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1837607/000183760726000033/aeon-20260429xdef14a.htm","source_date":"2026-04-29T00:00:00+00:00","retrieved_at":"2026-05-15T22:13:53.217543+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.797,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.594,"cross_source_agreement":0.75,"temporal_completeness":0.667},"diagnostics":{"published_claims":8,"factual_claims":8,"claims_with_linked_evidence":8,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":3,"temporal_claims_with_valid_from":2,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","committee","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-16T13:53:35.550143+00:00","observed_at":"2026-10-16T13:53:35.550143+00:00","reviewed_at":"2026-10-16T13:53:35.550143+00:00","verified_at":"2026-10-16T13:53:35.550143+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":8,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/aeon-biopharma-inc/evidence","section":"evidence","href":"https://registry.alpha.ac/api/public/companies/aeon-biopharma-inc?format=record&section=evidence","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}